Article
Monocytes with Oncogenic Mutation JAK2 V617F as a Tool for Studies of the Pathogenic Mechanisms of Myelofibrosis.
Bulletin of experimental biology and medicine - 1 Mar 2018
Silyutina A A, Gin I I, Prikhod'ko S S, Zhuk S V, Butylin P A, Zaritskii A Yu
Abstract excerpt
We analyzed previously generated stable monocyte-derived cell line carrying mutation JAK2 V617F. Evaluation of the expression of pro- and antifibrotic factors revealed changes in the production of MMPs and their inhibitors, growth factors, galectin-3, and pentraxin 3 in cells carrying mutation JAK2 in comparison with control non-modified cells.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
